LIQ-001: Phase I started

Liquidia began the single-blind, U.S. Phase I LIfT trial to compare 2 doses of LIQ-001 plus Fluzone vs. Fluzone alone in 75 healthy volunteers ages 18-49. The trial plans to enroll an additional 75 h...